Trijardy XR 1000 mg/1

Trijardy XR 1000 mg/1 combines empagliflozin, linagliptin, and metformin hydrochloride for managing type 2 diabetes. This extended-release tablet supports blood sugar control and may reduce cardiovascular risks. Ideal for adults needing combination therapy.

Trijardy XR 1000 mg/1 is primarily used for managing type 2 diabetes in adults. It combines three active ingredients—empagliflozin, linagliptin, and metformin hydrochloride—to help control blood sugar levels. This medication is often prescribed when diet and exercise alone are not enough. It may also support cardiovascular health in certain patients.

Common effects of Trijardy XR 1000 mg/1 may include urinary tract infections, hypoglycemia, and gastrointestinal issues like diarrhea or nausea. Some users report fatigue or headache. These effects vary and are not experienced by everyone. Always consult a healthcare provider for personalized advice.

Handle Trijardy XR 1000 mg/1 with care, especially if you have kidney problems, pancreatitis, or a history of low blood sugar. Avoid alcohol while using this medication, as it may increase the risk of side effects. Store at room temperature, away from moisture and heat.

Trijardy XR 1000 mg/1 may interact with other medications, including insulin, sulfonylureas, and certain antibiotics. Always inform your healthcare provider about all medications you are taking. Alcohol and some over-the-counter drugs may also affect its efficacy or increase side effects.